<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref66">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ledgerwood</surname>
    <given-names>J. E.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>C. J.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Gordon</surname>
    <given-names>I. J.</given-names>
   </name>
   <name>
    <surname>Enama</surname>
    <given-names>M. E.</given-names>
   </name>
   <name>
    <surname>Hendel</surname>
    <given-names>C. S.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2011</year>). 
  <article-title>DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials</article-title>. 
  <source>Lancet Infect. Dis.</source>
  <volume>11</volume>, 
  <fpage>916</fpage>â€“
  <lpage>924</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(11)70240-7</pub-id>, PMID: 
  <?supplied-pmid 21975270?>
  <pub-id pub-id-type="pmid">21975270</pub-id>
 </mixed-citation>
</ref>
